KROS - Wall Street Estimates - Keros Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 11.2

1.08 %

$ 454 M

Market Cap

-2.24

P/E

Price Target Average

810.71%

Revenue Forecast Estimate

705.65%

EBIT Estimate

54.71%

Net Income Estimate

11.68%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Keros Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for KROS of $102 , with forecasts ranging from a low of $96 to a high of $107 .

KROS Lowest Price Target Wall Street Target

96 USD 757.14%

KROS Average Price Target Wall Street Target

102 USD 810.71%

KROS Highest Price Target Wall Street Target

107 USD 855.36%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free